Organization and Nature of Operations (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2022

Dec. 31, 2021

	Allocation
Tangible Assets Acquired:
Net working capital	$	(1,186,622	)
Right of use asset		40,093
Lease liability		(46,970	)
Net Tangible Assets Acquired	$	(1,193,499	)

Intangible Assets Acquired:
Licenses and trademarks
Brain Scientific Trade Name		133,000
MemoryMD Trade Name		504,000
NeuroCap Trade Name		188,000
Neuro EEG Trade Name		11,000
Patent products
NeuroCap Developed Technology		10,242,000
NeuroEEG Developed Technology		35,000
Net Intangible Assets Acquired	$	11,113,000

Total Fair Value of Assets Acquired	$	9,919,501

Consideration:
Fair value of equity received		7,240,222
Liabilities assumed		2,987,152
Loans forgiven		605,311
Total consideration	$	10,832,685

Goodwill	$	913,184

Tangible Assets Acquired:	Allocation

Net working capital		(1,186,622	)
Right of use asset		40,093
Lease liability		(46,970	)
Net Tangible Assets Acquired	$	(1,193,499	)

Intangible Assets Acquired:
Brain Scientific Trade Name		133,000
MemoryMD Trade Name		533,000
Neurocap Trade Name		188,000
Neuro EEG Trade Name		11,000
Customer Relationships		(29,000	)
NeuroCap Developed Technology		10,242,000
NeuroEEG Developed Technology		35,000
Total Fair Value of Assets Acquired	$	11,113,000

Consideration:
Fair value of equity received		7,240,222
Liabilities assumed		2,978,152
Loans forgiven		605,311
Goodwill	$	913,184

BRAIN SCIENTIFIC INC. S-1/A